BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 27592556)

  • 21. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depression and depressive symptoms in first episode psychosis.
    Romm KL; Rossberg JI; Berg AO; Barrett EA; Faerden A; Agartz I; Andreassen OA; Melle I
    J Nerv Ment Dis; 2010 Jan; 198(1):67-71. PubMed ID: 20061872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The epigenetic modulation of alcohol/ethanol and cannabis exposure/co-exposure during different stages.
    Dobs YE; Ali MM
    Open Biol; 2019 Jan; 9(1):180115. PubMed ID: 30958117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.
    Hambrecht M; Häfner H
    Aust N Z J Psychiatry; 2000 Jun; 34(3):468-75. PubMed ID: 10881971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis use predicts shorter duration of untreated psychosis and lower levels of negative symptoms in first-episode psychosis: a South African study.
    Burns JK; Jhazbhay K; Emsley R
    Afr J Psychiatry (Johannesbg); 2010 Nov; 13(5):395-9. PubMed ID: 21390411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study.
    Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Ajnakina O; Gayer-Anderson C; Colizzi M; Quattrone D; Behlke I; Shetty S; McGuire P; David AS; Murray R; Bhattacharyya S
    Lancet Psychiatry; 2016 Oct; 3(10):947-953. PubMed ID: 27567467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Relative Importance of Family History, Gender, Mode of Onset, and Age at Onsetin Predicting Clinical Features of First-Episode Psychotic Disorders.
    Compton MT; Berez C; Walker EF
    Clin Schizophr Relat Psychoses; 2017; 11(3):143-150. PubMed ID: 25367167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comorbid tobacco and other substance use and symptoms of anxiety and depression among hospitalised orthopaedic trauma patients.
    McCrabb S; Baker AL; Attia J; Balogh ZJ; Lott N; Palazzi K; Naylor J; Harris IA; Doran CM; George J; Wolfenden L; Skelton E; Bonevski B
    BMC Psychiatry; 2019 Jan; 19(1):28. PubMed ID: 30654783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-response effect between cannabis use and psychosis liability in a non-clinical population: evidence from a snowball sample.
    Ruiz-Veguilla M; Barrigón ML; Hernández L; Rubio JL; Gurpegui M; Sarramea F; Cervilla J; Gutiérrez B; James A; Ferrin M
    J Psychiatr Res; 2013 Aug; 47(8):1036-43. PubMed ID: 23684550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
    Ruiz-Veguilla M; Gurpegui M; Barrigón ML; Ferrín M; Marín E; Rubio JL; Gutiérrez B; Pintor A; Cervilla J
    Schizophr Res; 2009 Feb; 107(2-3):158-64. PubMed ID: 18805673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.
    Degenhardt L; Tennant C; Gilmour S; Schofield D; Nash L; Hall W; McKay D
    Psychol Med; 2007 Jul; 37(7):927-34. PubMed ID: 17288638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome in people with a psychotic illness: is cannabis protective?
    Waterreus A; Di Prinzio P; Watts GF; Castle D; Galletly C; Morgan VA
    Psychol Med; 2016 Jun; 46(8):1651-62. PubMed ID: 26965714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis as a risk factor for psychosis: systematic review.
    Semple DM; McIntosh AM; Lawrie SM
    J Psychopharmacol; 2005 Mar; 19(2):187-94. PubMed ID: 15871146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia.
    Leeson VC; Harrison I; Ron MA; Barnes TR; Joyce EM
    Schizophr Bull; 2012 Jun; 38(4):873-80. PubMed ID: 21389110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample.
    Auther AM; Cadenhead KS; Carrión RE; Addington J; Bearden CE; Cannon TD; McGlashan TH; Perkins DO; Seidman L; Tsuang M; Walker EF; Woods SW; Cornblatt BA
    Acta Psychiatr Scand; 2015 Jul; 132(1):60-8. PubMed ID: 25572323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moderating role of cannabis use between insight and depression in early psychosis.
    Elowe J; Golay P; Baumann PS; Solida-Tozzi A; Conus P
    Schizophr Res; 2020 Jan; 215():61-65. PubMed ID: 31780343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between cannabis consumption and childhood abuse in psychotic disorders: preliminary findings on the role of different patterns of cannabis use.
    Sideli L; Fisher HL; Murray RM; Sallis H; Russo M; Stilo SA; Paparelli A; Wiffen BDR; O'Connor JA; Pintore S; Ferraro L; La Cascia C; La Barbera D; Morgan C; Di Forti M
    Early Interv Psychiatry; 2018 Apr; 12(2):135-142. PubMed ID: 26560802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis use at a young age is associated with psychotic experiences.
    Schubart CD; van Gastel WA; Breetvelt EJ; Beetz SL; Ophoff RA; Sommer IE; Kahn RS; Boks MP
    Psychol Med; 2011 Jun; 41(6):1301-10. PubMed ID: 20925969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabis and stimulant disorders and readmission 2 years after first-episode psychosis.
    Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
    Br J Psychiatry; 2014 Jun; 204(6):448-53. PubMed ID: 24578446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demographic and clinical characteristics associated with comorbid cannabis use disorders (CUDs) in hospitalized patients with bipolar I disorder.
    Weinstock LM; Gaudiano BA; Wenze SJ; Epstein-Lubow G; Miller IW
    Compr Psychiatry; 2016 Feb; 65():57-62. PubMed ID: 26773991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.